Purpose and Scope of the Agreement. 1.1 As of the EFFECTIVE DATE, UPMC assigns to CNRS and INSERM, who accept it, thirteen point three percent (13.3%) of the ownership rights on the PATENTS and the right of priority attached to French patent application no. 15 53957. The PARTIES are therefore co-owners of the PATENTS in the following proportions: · sixty percent (60%) for BIOPHYTIS, · thirteen point four percent (13.4%) for UPMC, · thirteen point three percent (13.3%) for CNRS,
Appears in 3 contracts
Samples: Co Ownership Agreement (Biophytis SA), Co Ownership Agreement (Biophytis SA), Co Ownership Agreement (Biophytis SA)
Purpose and Scope of the Agreement. 1.1 As of From the EFFECTIVE DATE, UPMC assigns to the CNRS and INSERM, who which accept itthis, thirteen respectively sixteen point three seven per cent (16.7%) and sixteen point six percent (13.316.6 %) of the ownership property rights on to the PATENTS and the priority right of priority attached to French patent application no. 15 5395754761. The PARTIES are therefore co-owners of the PATENTS in the following proportions: · sixty fifty percent (6050%) for BIOPHYTIS, · thirteen sixteen point four percent seven per cent (13.416.7%) for UPMC, · thirteen sixteen point three percent seven per cent (13.316.7%) for the CNRS,
Appears in 3 contracts
Samples: Co Ownership Agreement (Biophytis SA), Co Ownership Agreement (Biophytis SA), Co Ownership Agreement (Biophytis SA)